Tembexa FDA Approval History
Last updated by Judith Stewart, BPharm on June 8, 2021.
FDA Approved: Yes (First approved June 4, 2021)
Brand name: Tembexa
Generic name: brincidofovir
Dosage form: Tablets and Oral Suspension
Company: Chimerix, Inc.
Treatment for: Smallpox
Tembexa (brincidofovir) is a nucleotide analog broad-spectrum antiviral indicated for use as a medical countermeasure for smallpox.
Development Timeline for Tembexa
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.